25964214|t|Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
25964214|a|Glial glutamate transporter, GLT-1, is the major Na(+)-driven glutamate transporter to control glutamate levels in synapses and prevent glutamate-induced excitotoxicity implicated in neurodegenerative disorders including Alzheimer's disease (AD). Significant functional loss of GLT-1 has been reported to correlate well with synaptic degeneration and severity of cognitive impairment among AD patients, yet the underlying molecular mechanism and its pathological consequence in AD are not well understood. Here, we find the temporal decrease in GLT-1 levels in the hippocampus of the 3xTg-AD mouse model and that the pharmacological upregulation of GLT-1 significantly ameliorates the age-dependent pathological tau accumulation, restores synaptic proteins, and rescues cognitive decline with minimal effects on Abeta pathology. In primary neuron and astrocyte coculture, naturally secreted Abeta species significantly downregulate GLT-1 steady-state and expression levels. Taken together, our data strongly suggest that GLT-1 restoration is neuroprotective and Abeta-induced astrocyte dysfunction represented by a functional loss of GLT-1 may serve as one of the major pathological links between Abeta and tau pathology. 
25964214	0	11	Ceftriaxone	Chemical	MESH:D002443
25964214	42	59	cognitive decline	Disease	MESH:D003072
25964214	112	117	mouse	Species	10090
25964214	127	146	Alzheimer's disease	Disease	MESH:D000544
25964214	177	182	GLT-1	Gene	20511
25964214	243	252	glutamate	Chemical	MESH:D018698
25964214	284	293	glutamate	Chemical	MESH:D018698
25964214	302	316	excitotoxicity	Disease	
25964214	331	358	neurodegenerative disorders	Disease	MESH:D019636
25964214	369	388	Alzheimer's disease	Disease	MESH:D000544
25964214	390	392	AD	Disease	MESH:D000544
25964214	426	431	GLT-1	Gene	6506
25964214	473	494	synaptic degeneration	Disease	MESH:D012183
25964214	511	531	cognitive impairment	Disease	MESH:D003072
25964214	538	540	AD	Disease	MESH:D000544
25964214	541	549	patients	Species	9606
25964214	626	628	AD	Disease	MESH:D000544
25964214	693	698	GLT-1	Gene	20511
25964214	737	739	AD	Disease	MESH:D000544
25964214	740	745	mouse	Species	10090
25964214	797	802	GLT-1	Gene	20511
25964214	918	935	cognitive decline	Disease	MESH:D003072
25964214	960	965	Abeta	Gene	14961
25964214	1039	1044	Abeta	Gene	14961
25964214	1080	1085	GLT-1	Gene	20511
25964214	1169	1174	GLT-1	Gene	20511
25964214	1210	1215	Abeta	Gene	14961
25964214	1282	1287	GLT-1	Gene	20511
25964214	1345	1350	Abeta	Gene	14961
25964214	Association	MESH:D018698	20511
25964214	Association	MESH:D012183	6506
25964214	Positive_Correlation	MESH:D018698	MESH:D019636
25964214	Negative_Correlation	MESH:D000544	20511
25964214	Positive_Correlation	MESH:D003072	20511
25964214	Association	MESH:D000544	6506
25964214	Association	MESH:D003072	6506
25964214	Negative_Correlation	MESH:D002443	MESH:D003072
25964214	Association	MESH:D002443	MESH:D000544
25964214	Negative_Correlation	14961	20511

